RNAZ earnings: a positive outcome, +10.5%

On May 15, 2024, Transcode Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.5% in the window around the event. It had already run +163.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.